Effect of donor age and sex on the outcome of liver transplantation.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 2965620)

Published in Hepatology on December 01, 1995

Authors

I R Marino1, H R Doyle, L Aldrighetti, C Doria, J McMichael, T Gayowski, J J Fung, A G Tzakis, T E Starzl

Author Affiliations

1: Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, PA 15213, USA.

Articles citing this

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation (1996) 1.22

Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts. World J Surg (2003) 0.97

Gender differences in liver donor quality are predictive of graft loss. Am J Transplant (2011) 0.96

Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg (1996) 0.95

Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl (2001) 0.93

Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. Dig Dis Sci (1997) 0.84

Gender affects reperfusion injury in rat liver. Dig Dis Sci (2001) 0.84

Using old liver grafts for liver transplantation: where are the limits? World J Gastroenterol (2014) 0.81

Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro? PLoS One (2015) 0.81

Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years. World J Surg (2013) 0.80

Expanded criteria donors. Clin Liver Dis (2014) 0.79

Hepatectomy in elderly patients: does age matter? World J Surg (2013) 0.79

Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc (1997) 0.79

Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation (1998) 0.79

Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis. PLoS One (2014) 0.79

Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts. Sci Rep (2016) 0.75

Comprehensive risk assessment for early neurologic complications after liver transplantation. World J Gastroenterol (2016) 0.75

Geographic Variation in Cold Ischemia Time: Kidney vs. Liver Transplantation in the United States, 2003-2011. Transplant Direct (2015) 0.75

The Correlation of Hepatic and Systemic Hemodynamics During Liver Transplantation: Quantification of Hepatic Resistance as an Actual Value. Medicine (Baltimore) (2015) 0.75

Correlation of Histopathologic Findings of Non-Graft Threatening Preservation/Reperfusion Injury in Time-Zero Liver Needle Biopsies With Short-Term Post-transplantation Laboratory Alterations. Hepat Mon (2015) 0.75

GRG profiles: Professor Ignazio Marino. Dig Dis Sci (2014) 0.75

Liver transplantation: making the best out of what we have. Dig Dis Sci (2002) 0.75

Articles cited by this

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest (1950) 9.22

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Successful liver transplantation from a living donor to her son. N Engl J Med (1990) 2.58

Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20

Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90

Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77

Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation (1991) 1.71

Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation (1992) 1.68

The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA (1992) 1.54

The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41

There is an answer to the shortage of organ donors. Surg Gynecol Obstet (1991) 1.29

Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation (1994) 1.18

Experience with human liver grafts obtained after donor cardiac standstill. Transplant Proc (1987) 1.18

Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16

The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation (1991) 1.05

No effect of H-Y minor histocompatibility antigen in zero-mismatched living-donor renal transplants. Transplantation (1994) 1.02

Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci (1993) 0.96

The successful use of older donors for liver transplantation. JAMA (1989) 0.95

Effect of age on liver function. Geriatrics (1975) 0.94

The use of older donor livers for hepatic transplantation. Transplantation (1990) 0.92

Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet (1993) 0.92

[Variations in urinary creatinine and endogenous creatinine clearance due to age]. Ugeskr Laeger (1971) 0.92

The impact of gender on renal transplantation. Transplantation (1994) 0.91

Donor-specific factors predict graft function following liver transplantation. Transplant Proc (1990) 0.85

Alterations in the liver with ageing. Clin Gastroenterol (1985) 0.85

Elderly liver donor. Lancet (1993) 0.83

The liver, biliary tract and pancreas in the aged: an anatomic and laboratory evaluation. J Am Geriatr Soc (1957) 0.80

Procurement of liver allografts from non-heart beating donors. Transplant Proc (1990) 0.80

Donor gender does not affect liver transplantation outcome in children. Dig Dis Sci (1990) 0.79

Impaired initial function in liver grafts from donors > 50 years of age. Transplant Proc (1993) 0.79

Selection criteria for liver donation: a review. Transpl Int (1993) 0.78

Is it safe to liberalize donor criteria to include those over age 60 and those weighing over 90 kg? Transplant Proc (1993) 0.78

Age greater than 50 years is not a contraindication for liver donation. Transplant Proc (1991) 0.78

Donor selection for orthotopic liver transplantation: lack of an effect of gender or cytomegalovirus (CMV) status. Transplant Proc (1990) 0.78

Does donor age exclude liver grafting? Transplant Proc (1993) 0.78

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

The portal circulation: I. The action of adrenaline and pituitary pressor extract. J Physiol (1932) 6.88

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03

Experience with 150 liver resections. Ann Surg (1983) 3.01

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Liver transplantation in adults. Hepatology (1982) 2.89